New chemo combo tested to wipe out tough breast cancer before surgery
NCT ID NCT03301350
Summary
This study tested a specific sequence of four chemotherapy drugs given before surgery (neoadjuvant therapy) for people with triple-negative breast cancer, a type that doesn't respond to hormone therapies. The main goal was to see if this treatment could completely eliminate the invasive cancer in the breast and lymph nodes by the time of surgery. Researchers also tracked how well patients tolerated the treatment and whether the cancer stayed away for two years after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aspirus Regional Cancer Center Wausau
Wausau, Wisconsin, 54401, United States
-
Columbia St. Mary's Cancer Center
Milwaukee, Wisconsin, 53211, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
ProHealth Care
Waukesha, Wisconsin, 53188, United States
-
Swedish American Hospital
Rockford, Illinois, 61104, United States
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.